The NRF2-LOC344887 signaling axis suppresses pulmonary fibrosis

[1]  Kacper Lechowicz,et al.  COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection , 2020, Journal of clinical medicine.

[2]  A. Wells,et al.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.

[3]  Donna D. Zhang,et al.  NRF2 negatively regulates primary ciliogenesis and hedgehog signaling , 2020, PLoS biology.

[4]  M. Kreuter,et al.  Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. , 2020, The Lancet. Respiratory medicine.

[5]  H. Lou,et al.  Trans-4,4'-dihydroxy stilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response. , 2019, Free radical biology & medicine.

[6]  Roshini Sathiaseelan,et al.  lncRNA FENDRR Exhibits Anti-Fibrotic Activity in Pulmonary Fibrosis. , 2019, American journal of respiratory cell and molecular biology.

[7]  Donna D. Zhang,et al.  Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation. , 2019, Cell chemical biology.

[8]  G. Raghu,et al.  Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis , 2019, European Respiratory Review.

[9]  Abdullahi Umar Ibrahim,et al.  Genome Engineering Using the CRISPR Cas9 System , 2019 .

[10]  E. Wagner,et al.  Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation. , 2019, The Journal of clinical investigation.

[11]  Huan Wang,et al.  Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140 , 2019, Molecular and Cellular Biology.

[12]  Lei Wang,et al.  Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress , 2019, Redox biology.

[13]  Donna D. Zhang,et al.  Redox regulation by NRF2 in aging and disease. , 2019, Free radical biology & medicine.

[14]  Wei Peng,et al.  lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial–mesenchymal transition by competitively binding miR-141-3p , 2019, Cell Death & Disease.

[15]  Qinqin Jin,et al.  Polydatin attenuates reactive oxygen species‐induced airway remodeling by promoting Nrf2‐mediated antioxidant signaling in asthma mouse model , 2019, Life sciences.

[16]  Jian Gao,et al.  Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT‐mediated PF , 2018, Journal of cellular physiology.

[17]  Xiaoguang Sun,et al.  RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE–dependent repression , 2018, Proceedings of the National Academy of Sciences.

[18]  Donna D. Zhang,et al.  NRF2 and the Hallmarks of Cancer. , 2018, Cancer cell.

[19]  Honggang Zhou,et al.  Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway , 2018, Respiratory Research.

[20]  G. Raghu,et al.  Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? , 2018, The Lancet. Respiratory medicine.

[21]  Q. Cui,et al.  Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis , 2018, Diabetes.

[22]  J. Mendell,et al.  Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.

[23]  Jian Gao,et al.  Nrf2 antioxidant pathway suppresses Numb-mediated epithelial–mesenchymal transition during pulmonary fibrosis , 2018, Cell Death & Disease.

[24]  J. Salciccioli,et al.  Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 , 2018, European Respiratory Journal.

[25]  Qi Zhang,et al.  The NmrA‐like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial–mesenchymal transition , 2017, Chemical biology & drug design.

[26]  David E. Williams,et al.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane‐treated colon cancer cells , 2017, Molecular nutrition & food research.

[27]  P. Liu,et al.  p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex , 2017, Molecular and Cellular Biology.

[28]  R. Ruggiero,et al.  Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review. , 2016, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[29]  H. Yao,et al.  Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis , 2016, Scientific Reports.

[30]  A. Günther,et al.  Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. , 2016, The Lancet. Respiratory medicine.

[31]  B. Herrmann,et al.  Mechanisms of long noncoding RNA function in development and disease , 2016, Cellular and Molecular Life Sciences.

[32]  Donna D. Zhang,et al.  Artemisitene activates the Nrf2‐dependent antioxidant response and protects against bleomycin‐induced lung injury , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Takafumi Suzuki,et al.  Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.

[34]  Lydia Han,et al.  Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. , 2015, European review for medical and pharmacological sciences.

[35]  L. Norton,et al.  N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties , 2014, Oncogene.

[36]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[37]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[38]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[39]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[40]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[41]  R. Kemler,et al.  Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation , 2011, Breast Cancer Research.

[42]  P. Wong,et al.  Dual roles of Nrf2 in cancer. , 2008, Pharmacological research.

[43]  Hye-Youn Cho,et al.  Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. , 2008, Antioxidants & redox signaling.

[44]  B. Beghé,et al.  Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis. , 2004, Respiratory medicine.

[45]  T. Baba,et al.  Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience. , 2017, Respiratory investigation.

[46]  Irene M Spinello,et al.  Pulmonary coccidioidomycosis. , 2008, Seminars in respiratory and critical care medicine.

[47]  P. Batra,et al.  Pulmonary coccidioidomycosis. , 1992, Journal of thoracic imaging.